Andrew D Hamilton

USPTO Granted Patents = 39

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 2.8

ph-index = 10

Forward Citations = 310(Granted Patents)

Location History:

Pittsburgh, PA (US) (1997 - 2000)
Guildford, CT (US) (2008 - 2013)
Oxfordshire, GB (2015)
New Haven, CT (US) (2015)
Guilford, CT (US) (2001 - 2016)
Oxford, GB (2013 - 2021)
New York, NY (US) (2019 - 2021)

Company Filing History:

University of South Florida

patents

12 out of 1,866

University of Pittsburgh

H. Lee Moffitt Cancer Center and Research Institute, Inc.

patents

6. 2 out of 1,310

University of Central Florida Research Foundation Inc

patents

where one patent can have more than one assignee

Years Active: 1997-2021

Loading Chart...

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11124479 - Oligopyrroles as antagonists of islet amyloid polypeptide oligomerization (2021-09-21),

2. 10946012 - Methods for inducing tumor regression, inhibiting tumor growth, and inducing apoptosis in breast tumors with geranylgeranyltransferase I inhibitors (2021-03-16),

3. 10723716 - Alpha-helix mimetics as modulators of Abeta self-assembly (2020-07-28),

4. 10500197 - Use of oligopyridylamides to inhibit mutant p53 amyloid formation and restore its tumor suppressor function (2019-12-10),

5. 9896668 - Substrate-mimetic AKT inhibitor (2018-02-20),

6. 9453049 - Substrate-mimetic Akt inhibitor (2016-09-27),

7. 9345682 - Inhibition of STAT3 signal transduction for human cancer therapy (2016-05-24),

8. 9040563 - Dual inhibitors of farnesyltransferase and geranylgeranyltransferase I (2015-05-26),

9. 9018209 - Compounds and methods for the treatment of viruses and cancer (2015-04-28),

10. 8993760 - Rock inhibitors and uses thereof (2015-03-31),

11. 8969578 - Inhibitors of STAT3 (2015-03-03),

12. 8822524 - Substrate-mimetic Akt inhibitor (2014-09-02),

13. 8609639 - Stat3 inhibitor having anti-cancer activity and methods (2013-12-17),

14. 8361970 - Growth factor binding molecules (2013-01-29),

15. 8153596 - Use of SH2 STAT3/STAT1 peptidomimetics as anticancer drugs (2012-04-10),

Title: The Innovative Journey of Andrew D Hamilton

Introduction: Andrew D Hamilton, a pioneering inventor hailing from Guilford, CT (US), has made significant contributions to the world of innovations with his groundbreaking ideas and inventions.

Latest Patents: Andrew D Hamilton's latest patents include cutting-edge technologies in the field of renewable energy, sustainable materials, and advanced medical devices, showcasing his commitment to creating a better future through innovation.

Career Highlights: With a career spanning over two decades, Andrew D Hamilton has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing solutions that push the boundaries of what is possible. His inventions have not only revolutionized industries but have also improved the quality of life for many around the globe.

Collaborations: Throughout his career, Andrew D Hamilton has collaborated with leading research institutions, universities, and innovative companies to bring his ideas to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many of his projects.

Conclusion: In conclusion, Andrew D Hamilton's passion for innovation, coupled with his relentless drive to make a positive impact on the world, sets him apart as a true trailblazer in the field of inventions. His work continues to inspire the next generation of inventors to think big, dream boldly, and create innovations that shape the future.

This text is generated by artificial intelligence and may not be accurate.